Tres Alchemix | DNX Capital

Company

Tres Alchemix

AI drug discovery platform R&D

Tres alchemix

Company Tres Alchemix
President Hisashi Hashimoto
Status Active
Category Deeptech
Website https://www.tresalchemix.com/
DNX Member
Yoshiki Shiraishi (Board) Akira Kurabayashi Aoi Nishimatsu

History with DNX Capital

2023 Founded
2025 Series A (lead investor)

Portfolio
Hot Topic

2026.07.26 Tres Alchemix to attend Genesis 2024 2025.09.26 Tres Alchemix Co. Ltd. Raises $4.4M In Series A Funding to Accelerate AI-Driven Drug Discovery